Document is current

Any future updates will be listed below

Discovery and validation of pyrrolopyrimidine-based VEGFR2 inhibitors targeting tumor angiogenesis via structure-based virtual screening, quantum chemical analysis, and in vitro assays

Crossref DOI link: https://doi.org/10.1007/s10822-025-00685-2

Published Online: 2025-10-28

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark